Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system - PubMed (original) (raw)
Comparative Study
. 1993 Dec;119(4):1029-40.
doi: 10.1242/dev.119.4.1029.
Affiliations
- PMID: 8306873
- DOI: 10.1242/dev.119.4.1029
Comparative Study
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
L H Tsai et al. Development. 1993 Dec.
Abstract
Cyclin-dependent kinase 5 (cdk5) was originally isolated on the basis of its close primary sequence homology to the human cdc2 serine/threonine kinase, the prototype of the cyclin-dependent kinases. While kinase activities of both cdc2 and cdk2 are detected in proliferating cells and are essential for cells to progress through the key transition points of the cell cycle, cdk5 kinase activity has been observed only in lysates of adult brain. In this study, we compared the activity and expression of cdk5 with that of cdc2 and cdk2 in the embryonic mouse forebrain. The expression and activity of cdk5 increased progressively as increasing numbers of cells exited the proliferative cycle. In contrast, the expression and activity of cdc2 and cdk2 were maximum at gestational day 11 (E11) when the majority of cells were proliferating and fell to barely detectable levels at E17 at the end of the cytogenetic period. Immunohistochemical studies showed that cdk5 is expressed in postmitotic neurons but not in glial cells or mitotically active cells. Expression of cdk5 was concentrated in fasciculated axons of postmitotic neurons. In contrast to other cell division cycle kinases to which it is closely related, cdk5 appears not to be expressed in dividing cells in the developing brain. These observations suggest that cdk5 may have a role in neuronal differentiation but not in the cell division cycle in the embryonic nervous system.
Similar articles
- Comparison of munc-18 and cdk5 expression in the nervous system during mouse embryogenesis.
Han SH, Morgan JI. Han SH, et al. Neuroscience. 1999;94(3):955-64. doi: 10.1016/s0306-4522(99)00372-3. Neuroscience. 1999. PMID: 10579588 - Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. Meijer L, et al. Eur J Biochem. 1997 Jan 15;243(1-2):527-36. doi: 10.1111/j.1432-1033.1997.t01-2-00527.x. Eur J Biochem. 1997. PMID: 9030781 - Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm.
Ino H, Chiba T. Ino H, et al. Brain Res. 1996 Sep 2;732(1-2):179-85. doi: 10.1016/0006-8993(96)00523-9. Brain Res. 1996. PMID: 8891282 - Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators.
Tang D, Wang JH. Tang D, et al. Prog Cell Cycle Res. 1996;2:205-16. doi: 10.1007/978-1-4615-5873-6_20. Prog Cell Cycle Res. 1996. PMID: 9552397 Review. - [The characterization of human cdc2 kinase and CDK2].
Yasuda H, Kamijo M, Ohba Y. Yasuda H, et al. Yakugaku Zasshi. 1993 Dec;113(12):829-46. doi: 10.1248/yakushi1947.113.12_829. Yakugaku Zasshi. 1993. PMID: 8301538 Review. Japanese.
Cited by
- p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
Bankston AN, Li W, Zhang H, Ku L, Liu G, Papa F, Zhao L, Bibb JA, Cambi F, Tiwari-Woodruff SK, Feng Y. Bankston AN, et al. J Biol Chem. 2013 Jun 21;288(25):18047-57. doi: 10.1074/jbc.M113.453688. Epub 2013 May 3. J Biol Chem. 2013. PMID: 23645679 Free PMC article. - CDK5 Deficiency Does not Impair Neuronal Differentiation of Human Induced Pluripotent Stem Cells but Affects Neurite Outgrowth.
Mucci S, Clas GS, Allio CP, Rodríguez-Varela MS, Isaja L, Marazita M, Sevlever GE, Scassa ME, Romorini L. Mucci S, et al. Mol Neurobiol. 2025 Jan;62(1):918-934. doi: 10.1007/s12035-024-04325-y. Epub 2024 Jun 28. Mol Neurobiol. 2025. PMID: 38937422 - Mitochondria in Early Forebrain Development: From Neurulation to Mid-Corticogenesis.
Fame RM, Lehtinen MK. Fame RM, et al. Front Cell Dev Biol. 2021 Nov 23;9:780207. doi: 10.3389/fcell.2021.780207. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34888312 Free PMC article. Review. - Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Sharma S, Zhang T, Michowski W, Rebecca VW, Xiao M, Ferretti R, Suski JM, Bronson RT, Paulo JA, Frederick D, Fassl A, Boland GM, Geng Y, Lees JA, Medema RH, Herlyn M, Gygi SP, Sicinski P. Sharma S, et al. Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8001-8012. doi: 10.1073/pnas.1912617117. Epub 2020 Mar 19. Proc Natl Acad Sci U S A. 2020. PMID: 32193336 Free PMC article. - Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.
Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Cáceres A. Paglini G, et al. J Neurosci. 1998 Dec 1;18(23):9858-69. doi: 10.1523/JNEUROSCI.18-23-09858.1998. J Neurosci. 1998. PMID: 9822744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous